Tech Company Financing Transactions
Ignyta Funding Round
Ignyta closed a $10 million investment round on 1/6/2014. Investors included Silicon Valley Bank.
Transaction Overview
Company Name
Announced On
1/6/2014
Transaction Type
Debt
Amount
$10,000,000
Round
Undisclosed
Investors
Silicon Valley Bank (Michael White)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11095 Flintkote Avenue d
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Ignyta is developing leading cancer treatments by developing selective tyrosine kinase inhibitors of the TrkA, TrkB, TrkC, ROS1 and ALK proteins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Lim
Chief Financial Officer
Jacob Chacko
Chief Medical Officer
Adrian Senderowicz
Chief Operating Officer
Zachary Hornby
Chief Scientific Officer
Robert Wild
VP - General Counsel
Matt Onaitis
Browse more venture capital transactions:
Prev: 1/6/2014: Centice venture capital transaction
Next: 1/6/2014: Vidible venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs